According to Janet Trunzo, executive vice president of regulatory affairs at AdvaMed, the end ofÂ negotiations for the next version of MDUFMA is near. Speaking at the annual meeting of the American Institute for Medical and Biological Engineering this morning, Trunzo told attendees to expect a press release about the proposal within days.Â The negotiations involving the user fee system have been between AdvaMed, FDA, and key members of Congress. MDUFMA must be reauthorized by the end of September, andÂ there's been a lot of closed door discussion about how itÂ should be restructured, along withÂ whether any ofÂ theÂ other provisions should be changed.Â Stay tuned for more information about the proposed agreement.
MD+DI Online is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.